PEN:NYSE
Penumbra Inc
$318.40
arrow_downward
-0.01%(-0.030) 1D
$319.40
arrow_upward
+0.31% (+1.00)bedtimeAfter hours
Closed: Sep 16, 4:00:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
$317.30
High
$319.33
Low
$317.30
Mkt. cap
12.54B
Avg. vol.
265.16K
Volume
816.98K
P/E ratio
78.20
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
Open
$317.30
High
$319.33
Low
$317.30
Mkt. cap
12.54B
Avg. vol.
265.16K
Volume
816.98K
P/E ratio
78.20
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
News stories
From web sources and news partners
Zacks
·
11 hours ago
Reasons to Retain Penumbra Stock in Your Portfolio for Now
TradingView
·
11 hours ago
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc